Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 28, 2022 16:05 ET
|
Opiant Pharmaceuticals
SANTA MONICA, Calif., June 28, 2022 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant” or “Company”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat...